Inovio Pharmaceuticals, Inc.
INO
$1.31
-$0.01-0.76%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | -67.43M | -84.93M | -84.95M | -108.09M | -87.76M |
| Total Depreciation and Amortization | 3.02M | 2.99M | 2.99M | 3.01M | 3.03M |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -9.95M | 4.56M | 2.55M | 22.30M | -1.79M |
| Change in Net Operating Assets | -6.23M | -5.96M | -9.22M | -6.14M | -8.27M |
| Cash from Operations | -80.58M | -83.35M | -88.63M | -88.92M | -94.79M |
| Capital Expenditure | -195.40K | -226.30K | -285.70K | -158.30K | -90.30K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | 59.30K | 59.30K |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 17.79M | 16.95M | 14.33M | 48.84M | 53.98M |
| Cash from Investing | 17.59M | 16.73M | 14.04M | 48.74M | 53.95M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | 0.00 | 0.00 |
| Issuance of Common Stock | 39.40M | 36.16M | 36.17M | 22.12M | 14.85M |
| Repurchase of Common Stock | -188.00K | -166.80K | -110.80K | -110.80K | -115.40K |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 30.95M | 16.99M | 16.99M | 33.05M | 16.06M |
| Cash from Financing | 70.17M | 52.98M | 53.05M | 55.06M | 30.80M |
| Foreign Exchange rate Adjustments | -- | -- | -- | 0.00 | 0.00 |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 7.17M | -13.64M | -21.54M | 14.88M | -10.04M |